INVESTOR RELATIONS

Agendia is a privately owned company that has raised funds in several investment rounds to develop and market its portfolio of in vitro cancer diagnostic services. The Company believes it is well positioned to benefit from the opportunity represented by the changing paradigm in cancer treatment towards personalized medicine and the market demand for molecular cancer diagnostics.

Original shareholders include the founders of Agendia and Stichting Fondsen Nederland that originated from the Netherlands Cancer Institute. For additional inquiries, please contact us at:  investorrelations@agendia.com.

Initial Public Offering